Wednesday 28 December 2011

Fabry’s Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2018


GlobalData, the industry analysis specialist, has released its new report, “Fabry’s Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of information and analysis on the global Fabry's Disease Therapeutics market. The report identifies the key trends shaping and driving the global Fabry's Disease Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Fabry's Disease Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Request a Sample for or Inquire before buying the report @ http://www.reportsnreports.com/reports/144147-fabrys-disease-therapeutics-pipeline-assessment-and-market-forecasts-to-2018.html

Scope
The report provides information on the key drivers and challenges of the Fabry's Disease Therapeutics market. Its scope includes -
• Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Fabry's Disease Therapeutics market revenues data from 2005 to 2009, forecast for eight years to 2018.
• Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
• Analysis of the current and future competition in the seven key countries Fabry's Disease Therapeutics market.
• Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
• Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Fabry's Disease Therapeutics market.
• Analysis of key recent licensing and partnership agreements in Fabry's Disease Therapeutics market



Tuesday 27 December 2011

Sickle Cell Anemia Therapeutics - Pipeline Assessment and Market Forecasts to 2018


GlobalData, the industry analysis specialist, has released its new report, “Sickle Cell Anemia Therapeutics - Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of information and analysis on the global Sickle Cell Anemia Therapeutics market. The report identifies the key trends shaping and driving the global Sickle Cell Anemia Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Sickle Cell Anemia Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope
The report provides information on the key drivers and challenges of the Sickle Cell Anemia Therapeutics market. Its scope includes –
• Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Sickle Cell Anemia Therapeutics market revenues data from 2005 to 2009, forecast for eight years to 2018.
• Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
• Analysis of the current and future competition in the seven key countries Sickle Cell Anemia Therapeutics market.
• Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
• Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Sickle Cell Anemia Therapeutics market.
• Analysis of key recent licensing and partnership agreements in Sickle Cell Anemia Therapeutics market

Request a Sample for or Inquire before buying the report @ http://www.reportsnreports.com/reports/144146-sickle-cell-anemia-therapeutics-pipeline-assessment-and-market-forecasts-to-2018.html.

Monday 26 December 2011

Industrial Controls in China to 2015


This study analyzes the industrial controls industry in China. It presents historical demand data (2000, 2005, 2010) and forecasts for 2015 and 2020 by control type (e.g., adjustable speed drive, computer numerical, programmable logic, proximity and positioning sensors, general-purpose conventional controls, special-purpose conventional controls) and market (e.g., durable goods, nondurable goods, nonmanufacturing). The study also considers market environment factors, details industry structure, evaluates company market share and profiles industry participants.

Request a Sample for or Inquire before buying the report @ http://www.reportsnreports.com/reports/142533-industrial-controls-in-china-to-2015.html

Table of Contents
SECTION PAGE
INTRODUCTIONx

I.EXECUTIVE SUMMARY1

II.MARKET ENVIRONMENT4
General4
Economic Overview5
Recent Economic Performance5
Economic Outlook7
Industrialization & Manufacturing Trends11
Gross Fixed Capital Formation Trends14
Currency Exchange Rates16
Pricing Patterns19
Technology Trends21
Conventional Functionality22
Communication/Systems Integration23
Legal & Regulatory Environment25
The Twelfth Five-Year Plan26

III.OVERVIEW29
Overview29
Industrial Control Demand by Sector31
International Environment33
World Supply & Demand34
Foreign Trade36

IV.ADVANCED INDUSTRIAL CONTROLS39
General39
Supply & Demand40
Adjustable Speed Drive Controls42
Demand42
Product Innovations & Producers45
Computer Numerical Controls46
Programmable Logic Controllers48
Demand50
Product Innovations & Producers51
Proximity & Positioning Sensors52
Other Solid-State Controls55
Parts & Accessories58
Control Systems Integration Services59
Industrial Control Software61

Explore Comprehensive list of Tables & Charts available in the report Industrial Controls in China to 2015.

Friday 23 December 2011

Baxter International Inc.: PharmaVitae Report


Strategic insight into the prospects for Baxter over the next six years. Picking out key strengths, weaknesses, opportunities and threats and evaluating the company's prescription pharmaceuticals outlook using a variety of cuts of the historical and forecast sales.

Request a Sample for or Inquire before buying the report @ http://www.reportsnreports.com/reports/144099-baxter-international-inc-pharmavitae-report.html

Features and benefits
• Gain insight into Baxter's strategic outlook across the next 6 years
• Analyze company sales forecasts by product, therapy area, lifecycle stage, geography, molecule type and source

This analysis examines the historical and forecast performance for Baxter in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.

Major points covered in Table of Contents of this report include:
• EXECUTIVE SUMMARY
• STRATEGIC INSIGHT
• COMPANY INTRODUCTION
• SALES ANALYSIS
• FINANCIAL ANALYSIS
• PRODUCT ANALYSIS
• APPENDIX
• Tables and Figures

Explore Comprehensive list of more than 40 Tables & Figures available in the report Baxter International Inc.: PharmaVitae Report.


Wednesday 21 December 2011

Ultrasound Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017


GlobalData’s report, “Ultrasound Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global ultrasound systems market. The report provides market landscape, competitive landscape and market trends information on the ultrasound systems market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market’s dynamics. The report also reviews the competitive landscape and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope
• Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
• Key segments covered include Color Doppler Ultrasound Systems (Portable Systems and Stand Alone Systems) and B/W Ultrasound Systems (Portable Systems and Stand Alone Systems).
• Annualized market revenues data from 2003 to 2010, forecast forward for seven years to 2017. Company shares data for 2010.
• Qualitative analysis of key market trends, market drivers, and restraints within the ultrasound systems market.
• The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
• Key players covered include Siemens Healthcare, GE Healthcare, Toshiba Medical Systems Corporation, Philips Healthcare, Hitachi Medical Corporation, ESAOTE S.p.A. and SonoSite, Inc.
Explore Comprehensive list of more than 170 Tables & Figures available in the report Ultrasound Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017.

Request a Sample for or Inquire before buying the report @ http://www.reportsnreports.com/reports/143769-ultrasound-systems-global-pipeline-analysis-competitive-landscape-and-market-forecasts-to-2017.html

Monday 19 December 2011

Summary Analysis of 2010 U.S. Voice of Customer Study Telematics and Infotainment and App-Store Applications


This customer research service provides the summary analysis on the preferences and willingness to pay for telematics, infotainment, and applications of consumer’s in the US. The study Summary Analysis of 2010 U.S. Voice of Customer Study Telematics and Infotainment and App-Store Applications highlights the awareness of current and future usage of telematics, infotainment and smart phone applications. It also illustrates the consumer’s interests and willingness for electric vehicle related applications. In addition, it educates the preferred input options required for all these services. Frost & Sullivan utilized a web-based survey methodology. It surveyed 1,212 vehicle owners who were 18 years or older, own a new generation smartphone (e.g. Apple, Blackberry, Droid), and own a vehicle that is no older than a 2007 model.

Request a Sample for or Inquire before buying the report @ 
http://www.reportsnreports.com/reports/143577-summary-analysis-of-2010-us-voice-of-customer-study-telematics-and-infotainment-and-app-store-applications.html

Table of Contents

1.EXECUTIVE SUMMARY
Summary of Key Findings
Key Findings

2.AWARENESS AND CURRENT AND FUTURE USAGE OF TELEMATICS
Awareness and Current and Future Usage
Awareness and Usage

3.AWARENESS AND USAGE OF SMARTPHONE APPS INSIDE VEHICLE
Awareness and Usage of Smart phone Apps
Awareness and Usage

4.HMI– PREFERRED INPUT OPTIONS FOR DIFFERENT IN- VEHICLE APPLICATIONS
Preferred Input Options
Preferred Options

5.INTEREST AND WILLINGNESS FOR ELECTRIC VEHICLE- RELATED APPS
Interest and Willingness on EV Apps
Interest and Willingness

6.APPENDICES
Definitions



Tuesday 13 December 2011

Craniomaxillofacial (CMF) Fixators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017


GlobalData’s new report, “Cranio Maxillofacial Fixation (CMF) Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global Craniomaxillofacial (CMF) fixators market. The report provides market landscape, competitive landscape and market trends information on the CMF fixators market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market’s dynamics. The report also reviews the competitive landscape and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope
• Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
• Key segments covered include Internal Cranio Maxillofacial Fixators and External Cranio Maxillofacial Fixators.
• Annualized market revenues data from 2003 to 2010, forecast forward for seven years to 2017. Company shares data for 2010.
• Qualitative analysis of key market trends, market drivers, and restraints within the CMF fixators market.
• The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
• Key players covered include Synthes, Stryker Corporation, Biomet, KLS Martin and Medartis AG.

Reasons to Buy
• Develop business strategies by understanding the trends and developments that are driving the CMF fixators market globally.
• Design and develop your product development, marketing and sales strategies.
• Develop market-entry and market expansion strategies.
• Identify key players best positioned to take advantage of the emerging market opportunities.
• Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
• What’s the next big thing in the CMF fixators market landscape? – Identify, understand and capitalize.
• Make more informed business decisions from the insightful and in-depth analysis of the global CMF fixators market and the factors shaping it.

Sunday 11 December 2011

Pet Care in Slovakia


Moderate growth of pet food
Pet Care in Slovakia - The overall pet care market grew moderately in 2011 in current value terms compared with the previous year. The number of dog and cat owners feeding their pets prepared food is increasing. With busy lifestyles pet owners want to feed their pets properly and quickly to spare time to care for their pet’s physical and psychological well-being. The range of pet food and pet care products on offer is becoming wider and more sophisticated. However, unlike in developed European countries, the percentage share of prepared food relative to the cat and dog population is low. Consequently, the potential for volume and value growth is promising.

Cats less common than dogs but becoming more popular
Dog food accounted for the majority of value sales in 2011. The number of dogs in Slovakia is almost four times larger than the number of cats. Cats are popular with retired single people (mostly women) and 2-person households without children. Those in the latter group have busy lifestyles and tend to work late, and consequently do not have time to walk a dog regularly.

Multinationals dominate but domestic brands gain attention
Dog and cat food remained relatively consolidated in 2011, with the top four producers accounting for just over half of total value sales. The leading multinationals РMars SK and Nestl̩ Slovensko sro Рenjoyed a significant share of sales thanks to early entry, wide product portfolios and strong advertising. Successful domestic companies include Ani-pet spol sro and Akvarium Kobolka sro. The leading brands lost some share to private label products in 2011.

Multiples lead but pet shops remain popular
Pet shops represented the leading distribution channel for dog and cat food in 2011. In other pet food and pet care products, pet shops remained the most important distribution outlets as well. Pet shops are still very popular with pet owners as they employ staff that can give advice and make recommendations. Pet superstores in shopping centres (Pet Center is one of the leading chains) are becoming popular thanks to their special price offers and discounts. Second position is held by supermarkets/hypermarkets with 34% market share.

Growth expected over forecast period
The Slovakia pet care market is expected to continue to grow moderately over the forecast period. The number of pet owners will continue to rise steadily, as will demand for high quality products. In particular, pet owners living in urban areas will become more interested in premium and super-premium products. Growth over the forecast period will continue to be driven by dog and cat food.

Friday 9 December 2011

Emerging Technologies: Stem cells


Emerging Technologies: Stem cells - Stem cell therapies will play an increasingly important role in the underserved field of regenerative medicine, as preclinical discoveries are translated into the clinical setting and product candidates slowly progress through a diverse pipeline.

Features and benefits
• A full stem cell pipeline by each therapeutic category from preclinical stage to registration candidates.
• Provides an insight into key players, recent deals and developments.

Browse All: Biotechnology Market Research Reports 

Highlights
Small and medium-sized research-led companies dominate the stem cells landscape, with a few large pharmaceutical companies beginning to invest in recent years. This sector is highly heterogeneous, consisting of different stem cells technology platforms, including embryonic and adult stem cells, applied in a wide range of therapy areas.

Geron’s recent divestment in the sector highlights the several technical challenges associated with the application of stem cells in certain therapy areas, in particular, the central nervous system.

Table Of Contents
ABOUT THIS REPORT
PharmaVitae Explorer database
Chapter structure
Introduction to stem cells
Stem cell pipeline
Key players
Data sourcing

EXECUTIVE SUMMARY
Strategic scoping and focus
Datamonitor key findings
Recent updates

INTRODUCTION TO STEM CELLS
Key findings
An introduction to stem cells
Types of stem cells
Pipeline snapshotAlthough bone marrow stem cell transplant has been routinely used for over 4 decades to treat hematological malignancies, the potential of stem cells to regenerate or replace highly specialized damaged or lost tissues in serious degenerative disorders or debilitating diseases, such as myocardial infarction, spinal cord injuries, ischemic stroke, macular degeneration, diabetes, and multiple sclerosis, has yet to be realized. Key limitations that still need to be addressed include successful delivery, differentiation, engraftment, integration, vascularization, functionality, and long-term safety of the transplanted cells. In view of this, several companies are currently exploiting more easily achievable goals, using a more drug-like approach that utilizes stem cells to alter physiological conditions within the damaged tissue and that indirectly promotes repair and regulates inflammatory and immunomodulatory pathways.
SWOT analysis
Strengths
Opportunities
Weaknesses
Threats

STEM CELL PIPELINE
Key findings
Stem cell pipeline overview
Cardiovascular
Central nervous system
Ophthalmology
Endocrine and metabolic disorders
Immunology and inflammation
Musculoskeletal
Other indications

THE KEY PLAYERS
Overview
Mesoblast
Osiris Therapeutics
Athersys
Gamida Cell
Cytori Therapeutics
Geron

APPENDIX
References
Datamonitor research
Journal papers
Exchange rates


Warner-Chilcott Plc: PharmaVitae Report


This analysis Warner-Chilcott Plc: PharmaVitae Report examines the historical and forecast performance for Warner-Chilcott in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.

Features and benefits
• Gain insight into Warner-Chilcott's strategic outlook across the next 6 years.
• Analyze company sales forecasts by product, therapy area, lifecycle stage, geography, molecule type and source.

Browse All: Pharmaceuticals Market Research

Table Of Contents
ABOUT THIS REPORT
PharmaVitae Explorer database
Chapter structure
Strategic insight
Company introduction
Sales analysis
Financial analysis
Product analysis
Data sourcing
Analyst consensus

EXECUTIVE SUMMARY
Key findings
Warner Chilcott prescription pharma sales outlook
Warner Chilcott financial outlook
SWOT analysis
Weaknesses
Opportunities
Threats

STRATEGIC INSIGHT
Proctor & Gamble acquisition will shape performance through to 2016
Portfolio has undergone substantial change
Impact of expiries increased by narrower product focus
Patent expiries non-negotiable – pre-erosion cash flow critical to future expansion
P&G acquisition will drive superior operating performance…
and provide platform for further diversification and strategic evolution

COMPANY INTRODUCTION
Background
M&A history



Thursday 8 December 2011

The Affluent Consumer Market in the U.S., 6th Edition


This completely new edition of Packaged Facts The Affluent Consumer Market in the U.S., 6th Edition finds an affluent consumer population that is considerably more upbeat than in 2009 when the last edition of the report was published. Experian Simmons National Consumer Study data show that affluent consumer confidence was on the rise in 2011. Compared to 2009, the proportion of affluent consumers reporting that they were financially better off than 12 months before had doubled. Spending among the affluent was up, and a wide range of consumer research organizations foresaw even more robust spending by affluent consumers in the coming year.

Packaged Facts The Affluent Consumer Market in the U.S. provides marketers with crucial insights into the mindset and behavior of affluent consumers. Affluent consumers remain the driving force of the American economy and play an outsized role in creating opportunities for marketers. The average income of households with an income of $150,000 or more remains 10 times higher than that of non-affluent households. Those in this income bracket make up only 7% of all consumer units but account for 17% of all consumer expenditures.

Browse All: Databook Market Research Reports

The first chapter of the report provides an in-depth analysis of the evolution of the mindset of affluent consumers from 2008 through 2011 and highlights opportunities generated by the shopping and spending patterns of affluent consumers. After a chapter that measures the current size and future growth of the affluent consumer market, the report presents a demographic profile of affluent consumers. The next chapter contains an assessment of the behavior of affluent consumers across generations. Another chapter demonstrates how affluent consumers have changed their post-recession spending priorities. Following an overview of how affluent consumers use financial services, the report tracks the behavior of affluent shoppers in the areas of food, the home, consumer electronics and automotive. The final chapter of the report analyzes the media consumption habits of affluent consumers with an emphasis on their involvement with social media.

Packaged Facts divides the affluent consumer market into three segments. Mass affluent consumers are adults who live in households with a household income of $100,000-$149,999. Highly affluent consumers are those living in households with a household income of $150,000-$249,999. Super-affluent consumers are adults in households with a household income of $250,000 or more.

The principal primary research source is the Experian Simmons National Consumer Study (NCS). The report includes data tracking the attitudes of affluent NCS respondents from 2007 through 2011. The report cites survey research data from a wide range of firms specializing in the affluent consumer market and includes a comprehensive analysis of relevant industry and trade publications. U.S. Government data sources include the American Community Survey and Current Population Survey of the U.S. Census Bureau and the Consumer Expenditure Survey of the Bureau of Labor Statistics.

Wednesday 7 December 2011

Collection of Chinese Laws and Administrative Regulations for Application and Approval of Foreign Investment Projects



Published: December 2011
No. of Pages: 728
Price: $ 2000
China is one of the fastest growing global economies. It has achieved and maintained an annual compound growth rate of GDP well above 9% since the 1980s. China has become the second largest economic entity in the world by 2010. It can be expected to China is one of places attracting foreign companies and investors around the world in the foreseeable future.

In China, government authorities administer and control the process of application and approval for registration, foreign investment projects and business scope for foreign investment enterprise by exorbitant administrative measures and regulations, moreover, these exorbitant administrative regulations are variable and lack of transparency. The legal procedure of setting up a foreign investment enterprise in China, unlike in Western countries, it requires comparatively complex documents. The application and approval of foreign investment projects and business scope is the most complex procedure in the process of setting up a foreign investment enterprise in China. This is involved with not only various Chinese laws and administrative regulations but also various Chinese government authorities. Lack of knowledge of the Chinese laws and administrative regulations, and the cultural difference between China and Western countries as well as the language barriers will increase the challenge faced by foreign companies and investors. Therefore, a detailed guidance of practical operation and a comprehensive and thorough knowledge of the latest Chinese laws and regulations have been become an essential prerequisite for foreign companies and investors.

Collection of Chinese Laws and Administrative Regulations for Application and Approval of Foreign Investment Projects and Business Scope is the fourth one of the Guidebook Series for Investing in China. It will provide the full text in England of variously existing latest in effective Chinese laws, administrative regulations and rules, and departmental regulations and rules for application and approval of foreign investment projects and business scope for foreign investment enterprise, which is associated with the third fascicle of the Guidebook Series for Investing in China----- Invest in China: A Guidebook for Application and Approval of Foreign Investment Projects and Business Scope.

Chapter 2 will introduce the framework and category of applicable Chinese laws, administrative regulations, including the departmental regulations and rules, for application and approval of foreign investment projects and business scope for foreign investment enterprise. With the help of the framework and category of various laws, administrative regulations, including the departmental rules and regulation, audience can clearly acquire a an overview of the latest Chinese laws and administrative regulations for application and approval of foreign investment projects and business scope for foreign investment enterprise, and lay the foundation for practical operation for application and approval of foreign investment projects and business scope for foreign investment enterprise.

Chapter 3 will provide the full text in England of variously existing latest in effective Chinese laws, administrative regulations and rules, and departmental regulations and rules for application and approval of foreign investment projects and business scope for foreign investment enterprise. In order to facilitate foreign investors to retrieve and understand the latest laws, administrative regulations and rules, and the departmental regulations and rules for application and approval of foreign investment projects and business scope of foreign investment enterprises that are in effective until now, these laws, administrative regulations and rules, and the departmental regulations and rules will be collected as two categories. The first category is involved with the application and approval of foreign investment projects. The second category is involved with the application and approval of business scope. Owing to the application and approval of business scope is governed by numerously individual administrative regulations or rules, as well as the measures for case issued by the State Council, the Ministry of Commerce and the sector’s competent authorities according to the foreign investment enterprise engaging in sector, so that the second category further is divided into some sub-categories, such as financial fields, commercial fields, service fields, as well as mineral resources exploration and exploitation fields. Then every sub-category further is divided into several specific categories in manner for case by case, such as bank, insurance company, commercial company, travel agency, logistic company, conference exhibit company, city planning service company, printing company, civil aviation company, direct marketing company, and so on.

After have skimmed through this guidebook, audience can clearly aware of a comprehensive and thorough knowledge of the latest Chinese laws and administrative regulations for application and approval of foreign investment projects and business scope for foreign investment enterprise, and begin the practical operation for application and approval of foreign investment projects and business scope for foreign investment enterprise with the Chinese government authorities smoothly.



Invest in China: A Guidebook for Application and Approval of Foreign Investment Projects


Published: December 2011
No. of Pages: 251
Price: $ 2000



China is one of the fastest growing global economies. It has achieved and maintained an annual compound growth rate of GDP well above 9% since the 1980s. China has become the second largest economic entity in the world by 2010. It can be expected to China is one of places attracting foreign companies and investors around the world in the foreseeable future.

China Investment Guidebook 3 - In China, government authorities administer and control the process of application and approval for registration, foreign investment projects and business scope for foreign investment enterprise by exorbitant administrative measures and regulations, moreover, these exorbitant administrative regulations are variable and lack of transparency. The legal procedure of setting up a foreign investment enterprise in China, unlike in Western countries, it requires comparatively complex documents. The application and approval of foreign investment projects and business scope is the most complex procedure in the process of setting up a foreign investment enterprise in China. This is involved with not only various Chinese laws and administrative regulations but also various Chinese government authorities. Lack of knowledge of the Chinese laws and administrative regulations, and the cultural difference between China and Western countries as well as the language barriers will increase the challenge faced by foreign companies and investors. Therefore, a detailed guidance of practical operation and a comprehensive and thorough knowledge of the latest Chinese laws and regulations have been become an essential prerequisite for foreign companies and investors.

Invest in China: A Guidebook for Application and Approval of Foreign Investment Projects and Business Scope is the third one of the Guidebook Series for Investing in China. It will focus on the application and approval of foreign investment projects and business scope, which is the most complex procedure in the process of setting up a foreign investment enterprise. It will provide not only a comprehensive and thorough knowledge of the latest Chinese laws and administrative regulations, but also the guidance of practical operation for application and approval of foreign investment projects and business scope for foreign companies and investors.

Browse All: Country Reports Market Research Reports

Chapter 2 will address the Chinese government authorities for examination and approval of foreign investment projects and business scope for foreign investment enterprise, and sketch an organizational chart of the government authorities for examination and approval for investment projects and business scope from the central government authorities, the government authorities of provinces, autonomous regions, municipalities directly under the Central Government to local government authorities. The aim of this chapter is to give direction of gateway for application and approval of investment projects and business scope for foreign investment enterprise.

Chapter 3 will elaborate the entire process of setting up a foreign investment enterprise in China, because the application and approval of foreign investment projects and business scope is the most significant procedure in the process of setting up a foreign investment enterprise.

Chapter 4 will introduce the applicable Chinese laws, administrative regulations, including the departmental regulations and rules, for application and approval of foreign investment projects and business scope for foreign investment enterprise. With the help of these various laws, administrative regulations, including the departmental rules and regulation, audience can clearly acquire a comprehensive and thorough knowledge of the latest Chinese laws and administrative regulations for application and approval of foreign investment projects and business scope, and lay the foundation for practical operation for application and approval of foreign investment projects and business scope for foreign investment enterprise.

Chapter 5 will introduce the practical operation for application and approval of foreign investment projects to guide investors step by step to go through the approval of the Chinese government authorities smoothly.

Chapter 6 will introduce the practical operation for application and approval of business scope for foreign investment enterprise in manner for case by case to guide foreign investors step by step to go through the approval of the Chinese government authorities smoothly.

The guidebook concludes in Chapter 7 by highlighting the significant suggestions for foreign companies and investors looking to achieve a successful application and approval for foreign investment projects and business scope for their companies and enterprises in China.

The another fascicle of the Guidebook Series for Investing in China--- Collection of Chinese Laws and Administrative Regulations for Application and Approval of Foreign Investment Projects and Business Scope will provide the full text in England of variously existing latest in effective Chinese laws, administrative regulations and rules, and departmental regulations and rules for application and approval of foreign investment projects and business scope for foreign investment enterprise, which is associated with this guidebook.



Monday 5 December 2011

European Markets for Orthopedic Large Joint Reconstructive Devices 2011


Published: December 2011
No. of Pages: 316
Price: $ 11495
In 2010, the combined European large joint orthopedic reconstruction device market was valued at over €1.9 billion. 

The countries covered in this report include:
• Austria
• Benelux
• France
• Germany
• Italy
• Portugal
• Scandinavia
• Spain
• Switzerland
• The United Kingdom


Despite the lower average selling prices offered in the German reconstruction device market, which had the most challenging pricing environment, it was the largest combined hip and knee reconstruction device market in Europe. Comparatively, the average price for orthopedic implants in Germany was lower than for Portugal, which has a significantly lower national income per capita. 

The market segments covered in this report European Markets for Orthopedic Large Joint Reconstructive Devices 2011 include:
• The knee reconstruction market
• The hip reconstruction market
• The bone cement market

Within the orthopedic large joint replacement and bone cement market, companies such as Biomet, DePuy Orthopaedics, Smith & Nephew, Stryker Orthopedics and Zimmer lead the market, among others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. 

E-Waste Recycling and Reuse Services Worldwide


Published: December 2011
No. of Pages: 216
Price: $ 4950

E-waste (electronic and electrical waste) recycling and reuse (R&R) services include a wide plethora of business types, such as collectors, de-manufacturers, material processors, asset managers, recyclers and refurbishers. Companies involved in the e-waste R&R industry purchase, refurbish, recycle and sell used (working or non-working), obsolete or surplus electronic and electrical (E&E) items - including everything from computers and cell phones to refrigerators and microwaves, as well as E&E components and parts - including CRT tubes, plastics and precious metals).

The e-waste R&R services industry is complex and sometimes could even be referred to as elusive. A simple route for an electronic item on its way to be recycled may entail collection from a garbage collector, triage by a dismantling company and then final processing by an end processor, such as a smelter or refiner. More complex routes may be more difficult to track and E&E items may find themselves undocumented in storage somewhere, overseas illegally or even in landfills. It is not uncommon for an e-waste collector, or even dismantler, to have little or no knowledge regarding the destination of its products. This situation is changing, however, as the regulatory framework for e-waste R&R services becomes more established - at least in some regions -and as the market continues to evolve and grow.

In 2010 the e-waste R&R services market value totaled close to $6.8 billion, up from $6.2 billion in 2009. Industry growth is expected to continue on its uphill path at least through the next decade, with collection services alone more than tripling by 2020. In 2010, China and India (out of the top ten country pool) are estimated to retain the largest market shares, in terms of value, with approximate shares of 23.7% and 21.6% respectively.

Growth in the e-waste R&R services industry is being spurred by the ever-increasing amounts of e-waste being created around the world, as purchases of electronic products are on the rise - in some regions dramatically, and as old E&E items become obsolete at an accelerated rate. Another driving factor in e-waste market growth is the growing recognition of valuable substances, such as lead, copper and gold, found in some e-waste components. These resources may be reclaimed at a profit and subsequently reused, which makes a lot more sense than simply throwing them away.

Browse All: Electronics Market Research Reports

Instances of corruption and "backyard recycling" may be somewhat exaggerated by the media, with both good and bad consequences. Pictures depicting hazardous working conditions, such as those of African children breathing fumes from burning copper wire, have helped to incite an increase in e-waste regulations and enforcement and have spurred the persistence of environmental watchdogs, such as the Basel Action Network and Greenpeace. Due to the persistence of groups such as these, the e-waste R&R services market is being upheld to a higher standard, although this increased scrutiny has also hindered growth for many involved in the industry.

E-Waste Recycling and Reuse Services Worldwide contains comprehensive historical data (2006-2010) and forecast data (2011-2020). This report identifies key trends and factors (such as the regulatory scene, new technologies, employment opportunities and economic drivers and challenges), which affect the size and direction of e-waste R&R market growth around the world. Profiles of more than a dozen major - or simply interesting - companies involved in the e-waste recycling and reuse industry are also included.


Sunday 4 December 2011

Lawn and Garden Products & Services in the U.S., 9th Edition


Published: December 2011
No. of Pages: 212
Price: $ 3750


This new edition continues Packaged Facts' tradition of comprehensive coverage of the U.S. lawn & garden market, valued at over $25 billion at retail in 2011. Closely linked to housing and employment trends, the market has suffered from the recession and its lingering drag on the economy, as well as other dampening factors including high energy prices and climate concerns. Some of those challenges also represent opportunities, however. For example, "green" gardening threatens traditional L&G (gas-powered machinery, synthetic chemicals), but also offers a way forward into a more sustainable future as a new generation of gardeners embrace trends including organic gardening and food gardening. The all-important aging Boomer segment also holds promise, including in professional lawn care services.

Browse All: Consumer Goods Market Research

Building on the continuity and coverage of previous editions, this fully updated report examines the U.S. market for lawn and garden products and services, including all products and services sold for maintenance, treatment, and enhancement of lawns, gardens, and landscapes. Focusing primarily on the consumer sector, the report Lawn and Garden Products & Services in the U.S., 9th Edition divides the market into three categories: Equipment (power and hand-held), Supplies (insecticides and fertilizer), and Services. Following an overview chapter detailing the market as a whole and providing cross-category perspective, the study offers separate in-depth chapter analyses of each category, including market size, composition, and projections; competitive trends; retail trends; and consumer trends.

An important new feature is consumer data from Packaged Facts' proprietary online survey conducted in September 2011, supplemented by cross-tabulated consumer survey results from Experian Simmons. Coverage includes trended levels of participation in home gardening and trended ownership and purchasing rates for three categories: power equipment, hand held tools, and supplies. Each of these categories is broken down by product type, with proprietary survey data indicating level of spending and outlet for purchasing. The report also presents demographic profiles and highlights of the U.S. gardener and of participants in each of the product categories, and quantifies consumer usage rates and spending trends for professional lawn care services.



Thursday 1 December 2011

World Windows & Doors Market to 2015


Published: October 2011
No. of Pages: 368
Price: $ 6300

World demand to rise 7% annually through 2015
World Windows & Doors Market to 2015 - Global demand for windows and doors is forecast to rise seven percent per year through 2015 to $200 billion, significantly exceeding the pace of growth registered between 2005 and 2010. However, advances will be exaggerated by an extremely weak 2010 base in the developed world, particularly in the US.

China to remain largest window and door market
China, the world’s largest national window and door market, will expand its share of global demand from 27 percent in 2010 to 29 percent in 2015. Continuing rapid economic growth and industrialization, as well as an increase in the average size of a housing unit in the country, will bolster gains. Although demand for windows and doors in China will expand robustly through 2015, it will represent a major slowdown in comparison to the performance of the past decade.

US market to post strong recovery
The US market for windows and doors will post a strong recovery and expand nine percent per year through 2015, after declining 25 percent between 2008 and 2010, when the country experienced a major economic recession that was spurred by the housing sector. Demand in Japan and Western Europe will also post solid recoveries after recent declines, although neither experienced problems as significant as the US did in 2009 and 2010.

Plastic windows and doors to be fastest growing types
Plastic windows and doors are projected to be the fastest growing products through 2015, although plastic doors will still account for less than ten percent of global door demand. Plastic windows will garner a larger share, more than 35 percent of global window demand in 2015.

Gains will be spurred by rising sales of fiberglass entry doors, which will capture market share from wood and steel. Fiberglass doors are less expensive, more aesthetically pleasing and more energyefficient than steel doors. While wood doors were traditionally seen to be more attractive than fiberglass doors, improvements in processing techniques have enabled manufacturers to make fiberglass that more closely resembles wood. Further gains for plastic windows and doors will be supported by continuing demand for vinyl windows because of their low cost, durability, minimal maintenance requirements and superior energy efficiency.

Energy-efficient windows and doors to outpace overall market
Through 2015, demand for energyefficient windows and doors will rise faster than the overall market because of increasing consumer awareness and government support in the form of tax credits. Sales of blast-resistant doors will also see above-average gains, especially in the nonresidential market in developed countries due to persisting security concerns.

Paint & Coatings Market to 2015


Published: November 2011
No. of Pages: 348
Price: $ 4900


US demand to exceed $25 billion in 2015
Paint & Coatings Market to 2015 - US demand for paint and coatings is forecast to exceed $25 billion in 2015. The market is expected to expand strongly in both volume and value terms, rebounding from the declines of the recessionimpacted 2005-2010 period. During this time, construction spending and manufactured goods output both fell, reducing coatings demand in the key architectural and manufacturing markets. Through 2015, growth will be fueled by renewed strength in manufacturing and construction activity as the US economy continues its economic recovery. Increasing domestic demand will boost production levels, as will favorable export opportunities, particularly in Asia and Mexico.

Browse All: Chemicals Market Research

Architectural market to provide best opportunities
The architectural market will continue to account for the largest share of paint and coatings demand in the US. Advances will outpace those of the other major segments through 2015, promoted by renewed strength in the housing market. In particular, home building activity will rebound from the low 2010 level, boosting paint and coating sales. Going forward, the interior component of the architectural paint market will remain considerably larger than the exterior segment, and growth in demand for interior paint will outpace that for exterior paint. The outlook for exterior coatings will continue to be affected by the introduction of more efficient products, which can cover more square footage per gallon, as well as the growing popularity of siding materials, such as vinyl, which do not require painting. On the bright side, however, demand for exterior paint will be promoted by the rising use of one alternative siding material -- fiber cement -- in the US housing industry. Unlike vinyl, fiber cement siding can be painted. To the extent that fiber cement displaces vinyl siding, this trend will provide opportunities for exterior paint demand.

Sales of paint and coatings in manufacturing markets will expand at a respectable rate through 2015, reversing the downward trend of the 2000-2010 period. Among the various market segments, the furniture and fixture sector will have the best opportunities for growth, and will remain the leading outlet for coatings over the forecast period. However, the motor vehicle sector will post more rapid gains, regaining its position as the second largest outlet for coatings among manufacturing markets. Although demand will benefit from strong growth in motor vehicle output, this will be offset to some extent by a move toward smaller, more fuel-efficient automobiles at the expense of larger light vehicles such as sport utility vehicles. This will limit coatings volume growth given that smaller vehicles generally require less paint on a per vehicle basis.

Maintenance and specialty coatings will remain the smallest market through 2015. Advances in this segment will trail those of the architectural and manufacturing markets. This is due in part to the fact that demand for maintenance and specialty coatings was more insulated from the difficult economic conditions present during the 2005-2010 period, and will therefore also not be as positively impacted by the improved economic outlook as the other market segments. Key outlets include industrial maintenance, and road and bridge markets. Both are expected to advance at above-average rates through 2015, promoted by greater nonresidential improvement and repair activity, and greater spending directed toward the maintenance of the nation's aging infrastructure.

Wednesday 30 November 2011

World Bioplastics Market to 2015


Published: November 2011
Price: $ 6100


World demand to reach $2.9 billion in 2015
World Bioplastics Market to 2015 - Global demand for biodegradable and bio-based plastics will more than triple to over one million metric tons in 2015, valued at $2.9 billion. Bioplastics have moved past the initial phase of market introduction and are now experiencing robust increases in demand in virtually all parts of the world. Gains are being fueled by a number of factors, including consumer preferences for environmentally sustainable materials, improved performance of bioplastic resins with respect to traditional plastics, and the introduction of commodity plastics produced from bio-based sources. Ultimately, however,price considerations will be the main driver of bioplastic market success, and rising petroleum costs may allow some bioplastic resins to achieve price parity with conventional plastics by the end of the decade. Starch-based resins, PLA to pace biodegradables Biodegradable plastics accounted for 90 percent of the world bioplastics market in 2010. Excellent growth is forecast for the two leading biodegradable plastics, starch-based resins and polylactic acid (PLA), both of which will more than double in demand through 2015. More rapid growth is expected for PLA, which will benefit from advancements in compounding polymerization technology, as well as its relatively low cost compared to other bioplastics. Fastest gains for biodegradable plastics, however, will be seen for polyhydroxy-alkanoate (PHA) resins, which are just beginning to enter the commercial market.

Browse All: Chemicals Market Research

Bio-based polyethylene to offer best opportunities
Despite the strong advances for biodegradable resins, non-biodegradable biobased resins will be the primary driver of bioplastics demand through 2015 and beyond. Gains will be stimulated by the availability of commercial quantities of bio-based polyethylene from Braskem’s 200,000 metric ton per year plant in Brazil, which opened in late 2010. Two other bio-based polyethylene plants, as well as bio-based polypropylene and PVC facilities, are expected to open around 2015. Additionally, industrial production of fully bio-based PET is forecast to become a reality by the end of the decade.

Asia/Pacific region to be fastest-growing market;
Brazil to become leading producer Western Europe was the leading consumer of bioplastics in 2010, as the region’s environmentally conscious consumers have been the quickest to accept biobased and biodegradable products. Starch-based resins used in biodegradable bags are particularly popular in the region. North America was another major market for bioplastics in 2010, with PLA accounting for the majority of demand. However, the fastest gains in bioplastics demand through 2015 will be seen for the Asia/Pacific region, driven by robust growth in Japan and China.Currently, world bioplastics production is heavily concentrated in the US and Western Europe. This will change dramatically by 2015, as production of  bio-based polyethylene ramps up in Brazil, making the country the world’s leading producer of bioplastics. Furthermore, China and Thailand plan to open over 100,000 metric tons of new bioplastics capacity by 2020, making these countries major players in the global market.

Study coverage
This new Freedonia industry study, World Bioplastics, is priced at $6100. It presents historical demand data (2000, 2005, 2010) and forecasts for 2015 and 2020 by product, market, world region and for 16 major countries. The study also considers market environment factors, evaluates company market share and profiles 38 industry competitors.
Company Profiles
Profiles 38 global players such as Arkema, NatureWorks, Metabolix, BASF, Innovia Films,Novamont and Rodenburg Biopolymer



Tuesday 29 November 2011

US Filters Market to 2015


Published: November 2011
Price: $ 5100



US demand to exceed $12 billion in 2015
US Filters Market to 2015 - Demand for filters in the US is expected  to increase to just over $12 billion in 2015. This growth reflects an improvement over the weaker gains registered during the 2005 to 2010 period due to the economic recession that occurred during the latter half of that period. Advances will be spurred by improved manufacturing activity, and motor vehicle production
and sales, as well as strengthened environmental regulations -- particularly those involving reduced emissions from electric utilities and diesel engines, and better water quality. Additionally, heightened consumer concerns about air and water quality will boost demand for filters in the residential market.

Browse All: Environmental Market Research

Aftermarket sales to continue dominant role
Ongoing sales in the aftermarket, which accounts for the majority of demand, will also drive gains. The growing market penetration of such products as motor vehicle cabin air filters, diesel emissions filters, and home air and water filters will contribute to aftermarket demand growth. As the number of filters in operation increases and awareness among consumers of their recommended replacement schedule improves, demand for replacement filters will also increase. However, growth in the aftermarket will be offset somewhat by users’ tendency to replace filters less often than recommended by the manufacturers. The ongoing development of filters featuring longer lasting media or other technologies that extend
their useful life will also restrain sales of aftermarket filters.

Motor vehicles to remain largest market
The motor vehicle market will continue to account for the largest portion of total demand in 2015. Although the high level of price competition in this market will temper gains, advances will be aided by the large volume of these filters sold both as original equipment and in the aftermarket. Demand for filters in the industrial and manufacturing market is projected to post the fastest gains, driven by increased manufacturing activity.

Study coverage
This new Freedonia industry study, Filters, is priced at $5100. It presents historical demand data (2000, 2005 and 2010) plus forecasts for 2015 and 2020 by filter technology, product and market. The study also considers market environment factors, assesses industry structure, evaluates company market share and profiles 38 player



Friday 18 November 2011

Personal Accident and Health Insurance in India, Key Trends and Opportunities to 2015

Published: November 2011
No. of Pages: 209
Price: $ 1950


The report provides top-level market analysis, information and insights of the Indian personal accident and health insurance industry, including:
• The Indian personal accident and health insurance industry’s growth prospects by product category and customer segment
• The various distribution channels in the Indian personal accident and health insurance industry
• The competitive landscape in the personal accident and health insurance industry
• A description of the personal accident and health reinsurance market in India

Executive Summary
The Indian personal accident and health insurance market recorded steady growth over the report’s review period, withstanding the ill effects of global economic slowdown. Growth is expected to continue, with a forecast 22% annual growth over the next five years, and a decrease in capital requirements will create an attractive market for new entrants into the market.

While public-sector insurance providers constitute the majority of the market, private participants will continue to increase their market share in the forecast period. The introduction of new distribution channels is another key factor in the growth in the overall volume of new policies.

Four public companies hold more than 50% of the market share in the personal accident and health insurance market, although this dominance will be severely challenged by private companies in the forecast period. The key entry barrier into the market is brand recognition, and companies are expected to work towards aligning with stronger brands, both domestic and foreign, to create opportunities for collaborations or joint ventures.

Scope
This report provides a comprehensive analysis of the personal accident and health insurance market in India:
• It provides historical values for India’s personal accident and health insurance industry for the report’s 2006–2010 review period and forecast figures for the 2011–2015 forecast period
• It offers a detailed analysis of the key sub-segments in India’s personal accident and health insurance industry, along with market forecasts until 2015
• It covers an exhaustive list of parameters, including written premium, incurred loss, loss ratio, commissions and expenses, combined ratio, frauds and crimes, total assets, total investment income and retentions
• It analyses the various distribution channels for personal accident and health insurance products in India
• Using Porter’s industry-standard “Five Forces” analysis, it details the competitive landscape in India for the personal accident and health insurance business
• It provides a detailed analysis of the reinsurance market in India and its growth prospects
• It profiles the top personal accident and health insurance companies in India, and outlines the key regulations affecting them.

Reasons To Buy
• Make strategic business decisions using top-level historic and forecast market data related to the Indian personal accident and health insurance industry and each sector within it
• Understand the demand-side dynamics, key market trends and growth opportunities within the Indian personal accident and health insurance industry
• Assess the competitive dynamics in the personal accident and health insurance industry, along with the reinsurance segment
• Identify the growth opportunities and industry dynamics within key product categories
• Gain insights into key regulations governing the Indian insurance industry and its impact on companies and the industry's future

Key Highlights
• The growth in the Indian personal accident and health insurance market can be attributed to increasing healthcare expenditure, economic growth, and changing demographics
• The Indian personal accident and health insurance market has a significant number of public-sector insurers. Private accident and health insurers account for less than 50% of the total accident and health insurance written premium
• During the forecast period, public-sector insurers are expected to retain a major share of the market, while the private accident and health insurers are expected to increase their market share gradually in India
• The increasing penetration of major insurance companies and banks selling insurance policies to second- and third-tier cities in India will lead to an increase in accident and health insurance policy volumes in India during the forecast period
• Key challenges include low awareness of personal accident and health insurance, low penetration in rural areas, a lack of coverage for many existing diseases, and the ineffective distribution model in the country.




Thursday 17 November 2011

Peripheral Vascular Stents - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017


Published: November 2011
No. of Pages: 94
Price: $ 3500
GlobalData’s new report, “Peripheral Vascular Stents - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global peripheral vascular stents market. The report provides market landscape, competitive landscape and market trends information on the peripheral vascular stents market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.


Scope
- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include Fem-pop Stents, Iliac Artery Stents, Renal Stents, Carotid Artery Stents and Infrapop Stents.
- Annualized market revenues data from 2003 to 2010, forecast forward for 7 years to 2017. Company shares data for 2010.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within the peripheral vascular stents market. 
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include Cordis Corporation, Abbott Vascular, Boston Scientific Corporation, C.R.Bard, Inc. and Covidien (ev3).

Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the peripheral vascular stents market globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What’s the next big thing in the peripheral vascular stents market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global peripheral vascular stents market and the factors shaping it.



Nuclear Imaging Equipment - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017


Published: November 2011
No. of Pages: 102
Price: $ 3500



GlobalData’s new report, “Nuclear Imaging Equipment - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global nuclear imaging equipment market. The report provides market landscape, competitive landscape and market trends information on the nuclear imaging equipment market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market’s dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Browse All: Medical Devices Market Research

Scope
- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include SPECT, SPECT/CT, PET and PET/CT Systems.
- Annualized market revenues data from 2003 to 2010, forecast forward for seven years to 2017. Company shares data for 2010.
- Qualitative analysis of key market trends, market drivers, and restraints within the nuclear imaging equipment market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include GE Healthcare, Philips Healthcare and Siemens Healthcare.

Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the nuclear imaging equipment market globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
- What’s the next big thing in the nuclear imaging equipment market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global nuclear imaging equipment market and the factors shaping it.



Wednesday 16 November 2011

Spinal Non-Fusion Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2017


Published: November 2011
No. of Pages: 91
Price: $ 3500


GlobalData’s new report, “Spinal Non-Fusion Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2017” provides key data, information and analysis on the global spinal non-fusion devices market. The report provides market landscape, competitive landscape and market trends information on the spinal non-fusion devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market’s dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Browse All: Medical Devices Market Research Reports 

Scope
- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include Artificial Disc Replacement, Dynamic Stabilization and Interspinous Process Decompression (IPD) devices.
- Annualized market revenues data from 2003 to 2010, forecast forward for seven years to 2017.
- Qualitative analysis of key market trends, market drivers, and restraints within the spinal non-fusion devices market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include Medtronic, Synthes, DePuy and Zimmer Holdings.

Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the spinal non-fusion devices market globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
- What’s the next big thing in the spinal non-fusion devices market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global spinal non-fusion devices market and the factors shaping it.



MRI Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017


Published: November 2011
No. of Pages: 99
Price: $ 3500
GlobalData’s new report, “MRI Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global MRI systems market. The report provides market landscape, competitive landscape and market trends information on the MRI systems market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market’s dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.


Scope
- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include High Field MRI Systems, Mid Field MRI Systems and Low Field MRI Systems.
- Annualized market revenues data from 2003 to 2010, forecast forward for seven years to 2017. Company shares data for 2010.
- Qualitative analysis of key market trends, market drivers, and restraints within the MRI systems market. 
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies. 
- Key players covered include Siemens Healthcare, GE Healthcare, Philips Healthcare, Toshiba Medical Systems Corporation and Hitachi Medical Corporation.

Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the MRI systems market globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
- What’s the next big thing in the MRI systems market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global MRI systems market and the factors shaping it.

X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017


Published: November 2011
No. of Pages: 103
Price: $ 3500
GlobalData’s new report, “X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global X-Ray systems market. The report provides market landscape, competitive landscape and market trends information on the X-Ray systems market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market’s dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.


Scope
- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include Digital X - Ray Systems (Computed Radiography Systems and Digital Radiography Systems) and Analog X - Ray Systems.
- Annualized market revenues data from 2003 to 2010, forecast forward for seven years to 2017. Company shares data for 2010.
- Qualitative analysis of key market trends, market drivers, and restraints within the X-Ray systems market. 
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies. 
- Key players covered include Siemens Healthcare, GE Healthcare, Philips Healthcare, Shimadzu Corporation and Toshiba Medical Systems Corporation.

Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the X-Ray systems globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
- What’s the next big thing in the X-Ray systems market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global X-Ray systems market and the factors shaping it.

Tuesday 15 November 2011

Computed Tomography Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017


Published: November 2011
No. of Pages: 192
Price: $ 2500
GlobalData’s new report, “Computed Tomography Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017” provides key market data on the Computed Tomography Systems market in the BRICS countries. The report provides value ($m), volume (units) and average price ($) data for each segment and sub-segment within three market categories –Mid Slice Computed Tomography Systems, Low Slice Computed Tomography Systems and High Slice Computed Tomography Systems. The report also provides company shares and distribution shares data for the overall Computed Tomography Systems market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available.

This report BRICS computed tomography systems market is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

The emerging economies, comprising China, India, Brazil, Russia and South Africa, with a significantly large pool of under-served patients, represent the next big opportunity for the leading medical equipment and devices manufacturers. China remains the world’s most populous country and is consequently home to a large patient base. The country is home to more than 120 million people who are aged 65 or older—a population in continuous need of medical care. India, the second most populous country globally, is home to 1.2 billion people, approximately 5% of which are aged 65 or older. It’s estimated that shortly after 2020, India’s population will surpass China, making it the most populous country in the world. As the population continues to grow and people continue to age, the underlying demand for healthcare is also expected to increase.


Scope
- Market size data for Computed Tomography Systems market categories – Mid Slice Computed Tomography Systems, Low Slice Computed Tomography Systems and High Slice Computed Tomography Systems
- Annualized market revenues ($m), volume (units) and average price ($) data for each of the segments and sub-segments within the three market categories. Data from 2003 to 2010, forecast forward for seven years to 2017. 
- 2010 company shares and distribution shares data for the overall Computed Tomography Systems market in each of the aforementioned countries.
- Global corporate-level profiles of key companies operating within the Computed Tomography Systems market in BRICS.
- Key players covered include Siemens Healthcare, GE Healthcare, Toshiba Medical Systems Corporation, Philips Healthcare, and Hitachi Medical Corporation.

Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Computed Tomography Systems competitive landscape in BRICS.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.


Healthcare IT Market Outlook in Japan to 2017 - Hospital Information Systems and Medical Imaging Information Systems


Published: November 2011
No. of Pages: 68
Price: $ 2500


GlobalData’s new report, “Healthcare IT Market Outlook in Japan to 2017 - Hospital Information Systems and Medical Imaging Information Systems” provides key market data on the Japan Healthcare IT market. The report provides value (USD million) data for each segment and sub-segment within two market categories – Hospital Information Systems and Medical Imaging Information Systems. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Browse All: Medical Devices Market

Scope
- Market size and company share data for Healthcare IT market categories – Hospital Information Systems and Medical Imaging Information Systems.
- Annualized market revenues (USD million) data for each of the segments and sub-segments within two market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the two market categories.
- Global corporate-level profiles of key companies operating within the Japan Healthcare ITmarket.
- Key players covered include Fujitsu Limited, FUJIFILM Holdings Corporation, Software Service, Inc., CSI Co., Ltd., NEC Corporation, GE Healthcare and others.

Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Japan Healthcare IT competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.



Wednesday 9 November 2011

Polycystic Ovarian Syndrome (PCOS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018


Published: November 2011
No. of Pages: 78
Price: $ 3500


GlobalData, the industry analysis specialist, has released its new report, “Polycystic Ovarian Syndrome (PCOS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of information and analysis on the global PCOS market. The report identifies the key trends shaping and driving the global PCOS market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global PCOS sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

GlobalData estimates that the global Polycystic Ovarian Syndrome Therapeutics market was valued at $656m in 2010, and is expected to grow at a static Compound Annual Growth Rate (CAGR) of 2.6% over the next eight years, to reach $804m by 2018. The growing treated population which is mainly due to expanding prevalence of co-morbid conditions such as diabetes, obesity and dyslipidemia will drive steady growth in PCOS therapeutics market. Although treated patients are increasing but the market is showing static growth because of the unavailability of FDA approved and presence of off-label and generic products for treatment which are having lower patient satisfaction due to lower efficacy profiles since these products can not treat all the conditions such as hyperandrogenism, infertility, hyperglycemia and hirsutism, associated with PCOS. So still a huge unmet need exists in the management of treatment pattern with the help of more efficacious products which can cure all the conditions. In the pipeline of PCOS, majority of the participants are institutions or universities. Company participation is very low because most of the drugs which are under trial are generics and already being used for this indication either alone or in combination. Therefore current pipeline products are not going to impact the market significantly.

Scope
The report provides information on the key drivers and challenges of the PCOS market. Its scope includes -
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) PCOS market revenues data from 2005 to 2010, forecast for eight years to 2018.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. Pipeline candidates fall under major therapeutic classes such as Antiplatelate action, Ovulation inducer, Hypoglycemic, Antiandrogen, Progesterone derivative, Oral contraceptives, Antiobesity drugs and others.
- Analysis of the current and future competition in the global PCOS market. Key market player covered is Reliance Life Sciences Pvt. Ltd.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the PCOS therapeutic market.
- Analysis of key recent licensing and partnership agreements in PCOS market.

Reasons to buy
The report will enhance your decision making capability. It will allow you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global PCOS market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global PCOS market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global PCOS market landscape? – Identify, understand and capitalize.


Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017


Published: November 2011
No. of Pages: 89
Price: $ 3500

GlobalData’s new report, “Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators market. The report provides market landscape, competitive landscape and market trends information on the implantable cardioverter defibrillators market and cardiac resynchronization therapy defibrillators market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.


Scope
- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include Cardiac Resynchronisation Therapy - Defibrillators, Dual Chamber Implantable Cardioverter Defibrillators and Single Chamber Implantable Cardioverter Defibrillators.
- Annualized market revenues data from 2003 to 2010, forecast forward for 7 years to 2017. Company shares data for 2010.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within the implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators market. 
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies. 
- Key players covered include Medtronic, Boston Scientific, St. Jude Medical, BIOTRONIK and Sorin Group.

Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators market globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What’s the next big thing in the implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators market and the factors shaping it.